Literature DB >> 11256171

Human embryonic stem cell technology.

J M Jones1, J A Thomson.   

Abstract

Undifferentiated human embryonic stem (ES) cells can be cultured indefinitely and yet maintain the potential to form almost every cell in the adult human body. Therefore ES cells provide a model for understanding the differentiation and function of human tissue, offer new strategies for drug discovery and testing, and have the potential to provide new transplantation therapies for the treatment of a wide variety of human diseases. In this article, we describe the origin and properties of human ES cells, distinguish ES cells from other pluripotent stem cell lines, and discuss their implications for basic research and human medicine.

Entities:  

Mesh：

Year:  2000        PMID： 11256171     DOI： 10.1055/s-2000-12560

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN： 1526-4564            Impact factor:   1.303


  13 in total

Review 1.  Pluripotent stem cells: origin, maintenance and induction.

Authors:  Maria P De Miguel; Sherezade Fuentes-Julián; Yago Alcaina
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

Review 2.  Stem cell plasticity: the debate begins to clarify.

Authors:  Alexandros Spyridonidis; Robert Zeiser; Marie Follo; Yannis Metaxas; Jürgen Finke
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

3.  Nucleofection mediates high-efficiency stable gene knockdown and transgene expression in human embryonic stem cells.

Authors:  Kristi A Hohenstein; April D Pyle; Jing Yi Chern; Leslie F Lock; Peter J Donovan
Journal:  Stem Cells       Date:  2008-03-06       Impact factor: 6.277

4.  Removal of reprogramming transgenes improves the tissue reconstitution potential of keratinocytes generated from human induced pluripotent stem cells.

Authors:  Ken Igawa; Chikara Kokubu; Kosuke Yusa; Kyoji Horie; Yasuhide Yoshimura; Kaori Yamauchi; Hirofumi Suemori; Hiroo Yokozeki; Masashi Toyoda; Nobutaka Kiyokawa; Hajime Okita; Yoshitaka Miyagawa; Hidenori Akutsu; Akihiro Umezawa; Ichiro Katayama; Junji Takeda
Journal:  Stem Cells Transl Med       Date:  2014-07-14       Impact factor: 6.940

Review 5.  Minireview: beta-cell replacement therapy for diabetes in the 21st century: manipulation of cell fate by directed differentiation.

Authors:  Vijay Yechoor; Lawrence Chan
Journal:  Mol Endocrinol       Date:  2010-03-10

6.  Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells.

Authors:  Munenari Itoh; Maija Kiuru; Mitchell S Cairo; Angela M Christiano
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-09       Impact factor: 11.205

Review 7.  iPSC modeling of rare pediatric disorders.

Authors:  Bethany A Freel; Jordan N Sheets; Kevin R Francis
Journal:  J Neurosci Methods       Date:  2019-12-04       Impact factor: 2.390

8.  Identification of oxygen-sensitive transcriptional programs in human embryonic stem cells.

Authors:  Suzanne D Westfall; Shrikesh Sachdev; Padmalaya Das; Leonard B Hearne; Mark Hannink; R Michael Roberts; Toshihiko Ezashi
Journal:  Stem Cells Dev       Date:  2008-10       Impact factor: 3.272

9.  Protocols for investigating microRNA functions in human neural progenitor cells.

Authors:  Sandra Almeida; Celine Delaloy; Lei Liu; Fen-Biao Gao
Journal:  Methods Mol Biol       Date:  2012

10.  Integrating human stem cell expansion and neuronal differentiation in bioreactors.

Authors:  Margarida Serra; Catarina Brito; Eunice M Costa; Marcos F Q Sousa; Paula M Alves
Journal:  BMC Biotechnol       Date:  2009-09-22       Impact factor: 2.563
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.